1.Research Progress on the Pathogenesis of Lung Cancer Associated with Idiopathic Pulmonary Fibrosis.
Qiangwei LU ; Shan HAN ; Xiaoqiu LIU
Chinese Journal of Lung Cancer 2022;25(11):811-818
Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease (ILD) of unknown causes, which is characterized by pulmonary fibrosis. The median survival period after diagnosis is about 2-4 years. In recent years, the incidence rate of lung cancer associated with IPF (IPF-LC) is increasing, and the prognosis is worse than that of IPF alone. Pulmonary fibrosis may be closely associated with the occurrence and development of lung cancer. Although the pathogenesis of IPF-LC is still unclear, the current research shows that there are similarities between the pathogenesis of these two diseases at molecular and cellular levels. At present, the research on the cellular and molecular mechanism of lung cancer related to pulmonary fibrosis has become the focus of researchers' attention. This article reviews the related literature, focusing on the latest status of the cellular and molecular mechanisms and treatment of IPF-LC, hoping to help clinicians understand IPF-LC.
.
Humans
;
Idiopathic Pulmonary Fibrosis/complications*
;
Lung Neoplasms/complications*
2.Benign metastasizing leiomyma of lung: report of a case.
Li-juan WANG ; Zhen-zhu SUN ; Dong-ming LENG ; Chun WANG ; Xiao-feng YANG
Chinese Journal of Pathology 2008;37(2):143-144
Adult
;
Female
;
Humans
;
Leiomyoma
;
complications
;
Lung Neoplasms
;
complications
;
Uterine Neoplasms
;
complications
3.Herniation of malignant lung cavity.
Saurabh Kumar SINGH ; Rakesh BHARGAVA ; Zuber AHMAD ; Deepak K PANDEY ; Shirin NAAZ ; Vibhanshu GUPTA
Chinese Medical Journal 2008;121(17):1757-1758
Adenocarcinoma
;
complications
;
Female
;
Hernia
;
etiology
;
Humans
;
Lung Diseases
;
etiology
;
Lung Neoplasms
;
complications
;
Middle Aged
4.Pulmonary tuberous sclerosis - a case report.
Yap Piang KIAN ; J SINGH ; R MURUGASU
Singapore medical journal 1979;20(3):402-405
Adult
;
Female
;
Hemangioma
;
complications
;
Humans
;
Kidney Neoplasms
;
complications
;
Lipoma
;
complications
;
Lung Diseases
;
complications
;
diagnosis
;
Tuberous Sclerosis
;
complications
;
diagnosis
8.Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis.
Yu Zhou GAN ; Yu Hui LI ; Li Hua ZHANG ; Lin MA ; Wen Wen HE ; Yue Bo JIN ; Yuan AN ; Zhan Guo LI ; Hua YE
Journal of Peking University(Health Sciences) 2020;52(6):1001-1008
OBJECTIVE:
To study the differences between clinically amyopathic dermatomyositis (CADM) and typical dermatomyositis (DM) on clinical and immunological features.
METHODS:
By collecting clinical data of 106 CADM patients and 158 DM patients from January 2010 to June 2019 in the department of Rheumatology and Immunology, Peking University People's Hospital, the clinical characteristics and immunological features in the two groups were compared, and the distribution characters and the clinical meanings of myositis autoantibodies were discussed in the two groups respectively. Myositis autoantibodies were measured by immunoblotting according to the manufacturers' instructions.
RESULTS:
In the aspects of clinical manifestations, CADM presented more with onset of interstial lung diseases (ILD) compared with DM (20.7% vs. 7.6%, P=0.002), and CADM-ILD was more likely to be acute ILD (58.3% vs. 26%, P < 0.001), and there were no differences between CADM and DM in cutaneous manifestations, accompanied with connective tissue disease (CTD) and malignancy. In CADM, the positive rate of rheumatoid factors and antinuclear antibodies was lower in DM. The most common myositis specific autoantibodies (MSAs) in CADM were anti-MDA5 (36%), anti-PL-7 (11.2%) and anti-TIF-1γ (10.1%). The most common MSAs in DM were anti-Jo-1 (19.2%), anti-TIF-1γ (11.5%) and anti-MDA5 (11.5%). Anti-MDA5 was correlated with acute ILD and skin ulceration both in CADM and DM; in CADM, skin ulceration was not associated with the titer of anti-MDA5; while in DM, skin ulceration was associated with high titer of anti-MDA5. In DM, anti-TIF-1γ was correlated with heliotrope eruption, V/shawl neck sign, perionychia erythma and malignancy, and higher rate of malignancy was seen in all titers of the anti-TIF-1γ positive patients. In CADM, anti-TIF1-γ showed no correlation with clinical manifestations. The most common myositis associated autoantibody was anti-Ro-52 both in CADM and DM. In CADM, anti-Ro-52 was associated with Raynaud's phenomenon and chronic ILD, while in DM, anti-Ro-52 was associated with mechanic's hands, noninfectious fever and accompanied CTD.
CONCLUSION
Compared with DM, ILD is more likely to be acute in CADM. It is different between CADM and DM about the distribution of myositis autoantibodies and the clinical significance of the same myositis antibody, and the clinical significance of some myositis antibodies is related to titers.
Autoantibodies
;
Dermatomyositis/complications*
;
Humans
;
Lung Diseases, Interstitial
;
Neoplasms
9.Risk Factors and Pathogenic Mechanism for Secondary Primary Lung Cancer in Breast Cancer Patients: A Review.
Di CHEN ; Yaolai XIAO ; Kaize ZHONG
Chinese Journal of Lung Cancer 2022;25(10):750-755
Breast cancer and lung cancer are the two most common malignancies in China. With the continuous improvement of breast cancer diagnosis and treatment technology, the survival time of breast cancer patients has been prolonged, and the number of breast cancer patients with second primary lung cancer (SPLC) has increased. In addition, breast cancer is the most common primary cancer in female patients with SPLC, and SPLC is the main cause of death in this population. More and more physicians pay attention to this clinical phenomenon. This paper summarized the risk and risk factors of SPLC in breast cancer patients, and elaborated its pathogenesis, in order to provide a theoretical basis for the clinical management of breast cancer patients and achieve accurate early intervention as soon as possible.
.
Humans
;
Female
;
Lung Neoplasms/pathology*
;
Carcinoma, Non-Small-Cell Lung/pathology*
;
Breast Neoplasms/complications*
;
Neoplasms, Second Primary/pathology*
;
Risk Factors
10.Outcomes of Sleeve Lobectomy versus Pneumonectomy for Lung Cancer.
Hong Kyu LEE ; Hee Sung LEE ; Kun Il KIM ; Ho Seung SHIN ; Jae Woong LEE ; Hyoung Soo KIM ; Sung Woo CHO
The Korean Journal of Thoracic and Cardiovascular Surgery 2011;44(6):413-417
BACKGROUND: Sleeve lobectomy for lung cancer in close proximity to or involving the carina is widely accepted. Operative morbidity and mortality rates, recurrence, and survival rates have varied considerably across studies. MATERIALS AND METHODS: From March of 2005 to July of 2010, sleeve lobectomy was performed in 19 patients and pneumonectomy was performed in 20 patients. In this paper, the results of sleeve lobectomy and pneumonectomy for patients with lung cancer will be compared and evaluated. RESULTS: There were no postoperative complications in either group, but there was one mortality in the pneumonectomy group. There was better preservation of pulmonary function in the sleeve lobectomy group than the pneumonectomy group (p=0.066 in FVC, p=0.019 in FEV1). The 3-year survival rates were 46.7% in the sleeve lobectomy group and 54.5% in the pneumonectomy group (p=0.505). The 3-year disease-free survival rates were 38% in the sleeve lobectomy group and 45.8% in the pneumonectomy group (p=0.200). CONCLUSION: Sleeve lobectomy for lung cancer showed low mortality, low bronchial anastomotic complication rates, and good preservation of pulmonary function.
Disease-Free Survival
;
Humans
;
Lung
;
Lung Neoplasms
;
Pneumonectomy
;
Postoperative Complications
;
Recurrence
;
Survival Rate